Yung-Jue Bang

Yung-Jue Bang

UNVERIFIED PROFILE

Are you Yung-Jue Bang?   Register this Author

Register author
Yung-Jue Bang

Yung-Jue Bang

Publications by authors named "Yung-Jue Bang"

Are you Yung-Jue Bang?   Register this Author

100Publications

3881Reads

17Profile Views

TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy.

Cancers (Basel) 2020 Feb 3;12(2). Epub 2020 Feb 3.

Department of Internal Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12020334DOI Listing
February 2020

Safety, Pharmacokinetics, and Clinical Activity of Adavosertib in Combination with Chemotherapy in Asian Patients with Advanced Solid Tumors: Phase Ib Study.

Target Oncol 2020 Feb;15(1):75-84

Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-020-00701-5DOI Listing
February 2020

Therapeutic Co-targeting of WEE1 and ATM Downregulates PD-L1 Expression in Pancreatic Cancer.

Cancer Res Treat 2020 Jan 25;52(1):149-166. Epub 2019 Jun 25.

Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2019.183DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962488PMC
January 2020

HER2-targeted therapies - a role beyond breast cancer.

Nat Rev Clin Oncol 2020 Jan 23;17(1):33-48. Epub 2019 Sep 23.

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-019-0268-3DOI Listing
January 2020

The prognostic role of soluble TGF-beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy.

Cancer Med 2020 Jan 7;9(1):43-51. Epub 2019 Nov 7.

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.2677DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943145PMC
January 2020

A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer.

Gastric Cancer 2019 11 3;22(6):1206-1214. Epub 2019 Apr 3.

Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10120-019-00958-4
Publisher Site
http://dx.doi.org/10.1007/s10120-019-00958-4DOI Listing
November 2019

GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer.

Gastric Cancer 2019 09 27;22(5):932-940. Epub 2019 Feb 27.

Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-019-00943-xDOI Listing
September 2019

Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: phase Ib study.

Br J Cancer 2019 Aug 17;121(4):332-339. Epub 2019 Jul 17.

Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-019-0523-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738070PMC
August 2019

Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer.

Cancer Res Treat 2019 Jul 1;51(3):886-900. Epub 2018 Oct 1.

Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://www.e-crt.org/journal/view.php?doi=10.4143/crt.2018.3
Publisher Site
http://dx.doi.org/10.4143/crt.2018.375DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639236PMC
July 2019

Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer.

Cancer Res Treat 2019 Jul 3;51(3):1167-1179. Epub 2018 Dec 3.

Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2018.526DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639230PMC
July 2019

Challenges and insights of early oncology drug development in the Asia-Pacific region: introduction of phase I oncology clinical trial center and experience sharing for early clinical trials in Seoul National University Hospital, Korea.

Chin Clin Oncol 2019 Jun;8(3):27

Department of Internal Medicine, Clinical Trials Center, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2019.06.05DOI Listing
June 2019

Clinical significance of BRCA1 and BRCA2 mRNA and protein expression in patients with sporadic gastric cancer.

Oncol Lett 2019 May 8;17(5):4383-4392. Epub 2019 Mar 8.

Department of Pathology, Seoul National University College of Medicine, Seoul 110-799, Republic of Korea.

View Article

Download full-text PDF

Source
http://www.spandidos-publications.com/10.3892/ol.2019.10132
Publisher Site
http://dx.doi.org/10.3892/ol.2019.10132DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447901PMC
May 2019

Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells.

Cancer Lett 2018 08 3;430:123-132. Epub 2018 May 3.

Cancer Research Institute, Seoul National University, South Korea; Biomedical Research Institute, Seoul National University Hospital, South Korea; Department of Internal Medicine, Seoul National University College of Medicine, South Korea; Translational Medicine, Seoul National University College of Medicine, Seoul, South Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2018.04.037DOI Listing
August 2018

Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives.

Cancer Treat Rev 2018 May 22;66:104-113. Epub 2018 Apr 22.

Seoul National University College of Medicine, Seoul, South Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.04.004DOI Listing
May 2018

Phase I Pharmacokinetic Study of Nivolumab in Korean Patients with Advanced Solid Tumors.

Oncologist 2018 02 20;23(2):155-e17. Epub 2017 Nov 20.

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0528DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813749PMC
February 2018

Use of olaparib in patients with advanced gastric cancer - Authors' reply.

Authors:
Yung-Jue Bang

Lancet Oncol 2018 02;19(2):e76

Department of Internal Medicine, Seoul National University College of Medicine, Seoul 03080, South Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30030-5DOI Listing
February 2018

Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy.

Int J Clin Oncol 2017 Dec 5;22(6):1069-1075. Epub 2017 May 5.

Department of Radiation Oncology, Ewha Womans University School of Medicine, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul, 07985, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-017-1129-7DOI Listing
December 2017

Anti-tumor effects of NVP-BKM120 alone or in combination with MEK162 in biliary tract cancer.

Cancer Lett 2017 12 9;411:162-170. Epub 2017 Oct 9.

Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2017.10.002DOI Listing
December 2017

Skeletal muscle depletion predicts survival of patients with advanced biliary tract cancer undergoing palliative chemotherapy.

Oncotarget 2017 Oct 2;8(45):79441-79452. Epub 2017 Jun 2.

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.18345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668056PMC
October 2017

Impact of radiation dose in postoperative radiotherapy after R1 resection for extrahepatic bile duct cancer: long term results from a single institution.

Oncotarget 2017 Sep 21;8(44):78076-78085. Epub 2017 Apr 21.

Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.17368DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652838PMC
September 2017

Prospective Evaluation of the Clinical Implications of the Tumor Metabolism and Chemotherapy-Related Changes in Advanced Biliary Tract Cancer.

J Nucl Med 2017 08 2;58(8):1255-1261. Epub 2017 Mar 2.

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.116.186239DOI Listing
August 2017

Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study.

J Clin Oncol 2017 Aug 10;35(22):2535-2541. Epub 2017 May 10.

Patrick A. Ott, Dana-Farber Cancer Institute, Boston, MA; Michael J. Pishvaian, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC; Hope S. Rugo, University of California San Francisco, San Francisco, CA; Igor Puzanov, Roswell Park Cancer Institute, Buffalo, NY; Janice M. Mehnert, Rutgers Cancer Institute of New Jersey, New Brunswick; Marion Carrigan, Sanatan Saraf, and Mei Chen, Merck, Kenilworth, NJ; Yung-Jue Bang, Seoul National University College of Medicine, Seoul, Republic of Korea; Dominique Berton-Rigaud, Institut de Cancérologie de l'Ouest Centre René Gauducheau, Saint-Herblain; Jean-Charles Soria, Gustave Roussy and University Paris-Sud, Villejuif, France; Elena Elez, Vall d'Hebron Institute of Oncology, Barcelona, Spain; Kyaw L. Aung, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; and Juanita Lopez, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.5952DOI Listing
August 2017

HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma.

J Clin Oncol 2017 Aug 2;35(22):2558-2567. Epub 2017 Jun 2.

Manish A. Shah, Meyer Cancer Center, Meyer Cancer Center at Weill Cornell Medical College, Medical Oncology/Solid Tumor Program, New York, NY; Amit Garg and Mona Shing, Genentech, South San Francisco, CA; Rui-hua Xu, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou; Tianshu Liu, Zhongshan Hospital of Fudan University; Fan Xia, Roche (China) Holding, Ltd, Shanghai, People's Republic of China; Yung-Jue Bang, Seoul National University College of Medicine, Seoul, Republic of Korea; Paulo M. Hoff, Hospital Sírio Libanês, São Paulo, Brazil; Luis A. Herráez-Baranda, F. Hoffmann-La Roche Ltd, Basel, Switzerland; and Josep Tabernero, Vall d'Hebron University Hospital and and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.6852DOI Listing
August 2017

A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer.

Target Oncol 2017 08;12(4):463-474

Division of Cancer Medicine, Peter MacCallum Cancer Centre, 305 Grattan St, Melbourne, VIC, 3000, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-017-0502-9DOI Listing
August 2017

Findings of a 1303 Korean whole-exome sequencing study.

Exp Mol Med 2017 07 14;49(7):e356. Epub 2017 Jul 14.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/emm.2017.142DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565953PMC
July 2017

Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition.

Mol Cancer Ther 2017 06 21;16(6):1145-1154. Epub 2017 Feb 21.

Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-16-0669DOI Listing
June 2017

Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication.

J Nucl Med 2017 06 10;58(6):899-904. Epub 2016 Nov 10.

Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.116.182675DOI Listing
June 2017

Risk stratification and prognostic nomogram for post-recurrence overall survival in patients with recurrent extrahepatic cholangiocarcinoma.

HPB (Oxford) 2017 05 17;19(5):421-428. Epub 2017 Jan 17.

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hpb.2016.12.014DOI Listing
May 2017

Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer.

Gastric Cancer 2017 Mar 5;20(2):254-262. Epub 2016 May 5.

Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-016-0613-5DOI Listing
March 2017

Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer.

Gastric Cancer 2017 Jan 17;20(1):164-174. Epub 2015 Dec 17.

Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-015-0583-zDOI Listing
January 2017

Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells.

Int J Cancer 2017 Jan 21;140(1):109-119. Epub 2016 Oct 21.

Translational Medicine, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.30373DOI Listing
January 2017

Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant Chemotherapy.

J Breast Cancer 2016 Dec 23;19(4):394-401. Epub 2016 Dec 23.

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4048/jbc.2016.19.4.394DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204045PMC
December 2016

Phase II trial of dacomitinib in patients with HER2-positive gastric cancer.

Gastric Cancer 2016 Oct 18;19(4):1095-1103. Epub 2015 Nov 18.

Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-015-0567-zDOI Listing
October 2016

Outcome Analysis of Chemoradiation in Unresectable Pancreatic Cancer Focusing on Treatment Sequencing Strategy.

Anticancer Res 2016 10;36(10):5455-5461

Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.11125DOI Listing
October 2016

Capecitabine for the treatment of gastric cancer.

Expert Rev Gastroenterol Hepatol 2015 15;9(12):1471-81. Epub 2015 Oct 15.

a Department of Internal Medicine, Seoul National University Hospital and Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474124.2015.1096774DOI Listing
September 2016

Pertuzumab in gastrointestinal cancer.

Expert Opin Biol Ther 2016 23;16(2):243-53. Epub 2015 Dec 23.

a Department of Internal Medicine , Seoul National University Hospital , Seoul , Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2016.1126578DOI Listing
September 2016

Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial.

J Clin Oncol 2016 08 20;34(23):2728-35. Epub 2016 Jun 20.

Nick Pavlakis, Niall C. Tebbutt, Lara R. Lipton, John R. Zalcberg, John Simes, and David Goldstein, Australasian Gastro-Intestinal Trials Group; Nick Pavlakis, Royal North Shore Hospital, University of Sydney; Katrin M. Sjoquist, Andrew J. Martin, Eric Tsobanis, Sonia Yip, and John Simes, National Health and Medical Research Council Clinical Trials Centre, University of Sydney; Katrin M. Sjoquist, Cancer Care Centre, St George Hospital; Sonia Yip, Sydney Catalyst Translational Cancer Research Centre; Mark Wong, Westmead Hospital; David Goldstein, Prince of Wales Hospital, Sydney, New South Wales; Niall C. Tebbutt, Austin Health; Lara R. Lipton, Western Health; Andrew Strickland, Monash Medical Centre; John R. Zalcberg, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Yoon-Koo Kang, Asan Medical Center, University of Ulsan College of Medicine; Yung-Jue Bang, Seoul National University Hospital; Sun Young Rha, Yonsei University College of Medicine; Jeeyun Lee, Samsung Medical Center, Sungkyunkwan University School of Medicine; Jae-Yong Cho, Gangnam Severance Cancer Hospital, Yonsei University College of Medicine, Seoul; Jin Won Kim, Seoul National University Bundang Hospital, Seongnam, South Korea; Thierry Alcindor, McGill University Health Centre, Montreal, Quebec; Christopher J. O'Callaghan, National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario; and Margot J. Burnell, Saint John Regional Hospital, Saint John, New Brunswick, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.1901DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019744PMC
August 2016

Src as a Therapeutic Target in Biliary Tract Cancer.

Mol Cancer Ther 2016 07 22;15(7):1515-24. Epub 2016 Apr 22.

Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-16-0013DOI Listing
July 2016

Prognostic Role of Body Mass Index in Advanced Small Bowel Adenocarcinoma Patients Receiving Palliative Chemotherapy.

Nutr Cancer 2016 07 9;68(5):750-5. Epub 2016 Jun 9.

a Department of Internal Medicine , Seoul National University Hospital , Seoul , Korea.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/01635581.2016.1
Publisher Site
http://dx.doi.org/10.1080/01635581.2016.1180413DOI Listing
July 2016

Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.

PLoS One 2015 5;10(10):e0139749. Epub 2015 Oct 5.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0139749PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593598PMC
June 2016

Lapatinib in Combination With Capecitabine Plus Oxaliplatin in Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma: TRIO-013/LOGiC--A Randomized Phase III Trial.

J Clin Oncol 2016 Feb 30;34(5):443-51. Epub 2015 Nov 30.

J. Randolph Hecht, Zev A. Wainberg, and Dennis Slamon, David Geffen School of Medicine, University of California Los Angeles, Santa Monica; Michael F. Press, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA; Yung-Jue Bang, Seoul National University College of Medicine; Hyun C. Chung, Yonsei Cancer Center, Yonsei Cancer Research Institute, Yonsei University College of Medicine; Joon O. Park, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Shukui K. Qin, People's Liberation Army Cancer Center, Nanjing Bayi Hospital, Jiangsu; Jianming M. Xu, Affiliated Hospital of the Military Medical Science Academy, Beijing; Jin Li, Cancer Hospital of Shanghai Fudan University, Shanghai, People's Republic of China; Krzysztof Jeziorski, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Yaroslav Shparyk, Lviv State Regional Oncology Medical and Diagnostic Center, Lviv, Ukraine; Paulo M. Hoff, Sociedade Beneficente de Senhoras-Hospital Sirio Libanĕs, Sao Paolo, Brazil; Alberto Sobrero, Istituto di Ricovero e Cura a Carattere Scientifico San Martino Istituto Scientifico Tumori, Genova, Italy; Pamela Salman, Fundación Arturo López Pérez, Santiago, Chile; Svetlana A. Protsenko, Petrov Research Institute of Oncology, St Petersburg, Russia; Marc Buyse, International Drug Development Institute, Leuven, Belgium; Karen Afenjar, Vincent Houé, and Agathe Garcia, Translational Research in Oncology, Paris, France; Tomomi Kaneko and Saba Khan-Wasti, GlaxoSmithKline, Brentford, United Kingdom; and Yingjie Huang and Sergio Santillana, GlaxoSmithKline, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.6598DOI Listing
February 2016

The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer.

Am J Cancer Res 2015 15;5(11):3376-88. Epub 2015 Oct 15.

Department of Internal Medicine, Seoul National University HospitalSeoul, Korea; Cancer Research Institute, Seoul National University College of MedicineSeoul, Korea.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697684PMC
January 2016

Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer.

J Clin Oncol 2015 Nov 17;33(33):3858-65. Epub 2015 Aug 17.

Yung-Jue Bang, Seock-Ah Im, and Woo Ho Kim, Seoul National University College of Medicine; Jae Yong Cho, Yonsei University College of Medicine, Gangnam Severance Hospital; Yeul Hong Kim, Anam Hospital, Korea University College of Medicine; Joon Oh Park, Samsung Medical Center, Sungkyunkwan University School of Medicine; Hoo Geun Chun, Seoul St Mary's Hospital, Catholic University of Korea, Seoul; Keun-Wook Lee, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam; Eun-Kee Song, Chonbuk National University Medical School, Jeonju; Kyung Hee Lee, Yeungnam University Hospital, Daegu; Dae Young Zang, Hallym University Sacred Heart Hospital, Anyang, Korea; Anitra Fielding, Jacqui Rowbottom, Darren Hodgson, and Mark J. O'Connor, AstraZeneca, Macclesfield, United Kingdom; and Xiaolu Yin, Innovation Centre, AstraZeneca, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.0320DOI Listing
November 2015

Effect of lapatinib on oral digoxin absorption in patients.

Clin Pharmacol Drug Dev 2015 11 2;4(6):449-53. Epub 2015 Jun 2.

Seoul National University Hospital, Clinical Research Institute, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpdd.189DOI Listing
November 2015

The Prognostic Importance of the Number of Metastatic Lymph Nodes for Patients Undergoing Curative Resection Followed by Adjuvant Chemoradiotherapy for Extrahepatic Bile Duct Cancer.

J Gastrointest Surg 2015 Oct 4;19(10):1833-41. Epub 2015 Aug 4.

Department of Radiation Oncology, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, Republic of Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11605-015-2898-9
Publisher Site
http://dx.doi.org/10.1007/s11605-015-2898-9DOI Listing
October 2015